Acrivastine (Compound)

Synonyms:ACRIVASTINE, 87848-99-5, Semprex, Acrivastin, Acrivastinum, Acrivastina, BW 825C, BW-825C, BW A825C, UNII-A20F9XAI7W, CHEBI:83168, A20F9XAI7W, (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid, 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-, (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid, 2-Propenoic acid,3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2E)-, NCGC00182053-02, Acrivastinum [Latin], Acrivastina [Spanish], Acrivastine [USAN:INN:BAN], (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid, Acrivastine (USAN/INN), (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure, DSSTox_CID_2555, SCHEMBL4702, CHEMBL1224, DSSTox_RID_76625, DSSTox_GSID_22555, MLS006010115, BIDD:GT0209, BW270C, DTXSID6022555, Acrivastine, >=98% (HPLC), HMS3886E20, BCP06189, HY-B1510, ZINC3776633, Tox21_113015, AC-912, BDBM50487466, Benadryl Allgy Relief Plus Decongest, MFCD00869830, s5718, AKOS005067182, CS-6454, DB09488, NCGC00182053-03, (2E)-3-[6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-2-propenoic acid, (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid, AS-14623, L917, SMR004701250, CAS-87848-99-5, D02760, D70156, 54338-EP2308562A2, 848A995, A916142, Q342745, SR-01000942220, Q-200590, SR-01000942220-1, (E)-3-{6-[3-pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridyl}acrylic acid, 2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-

Pubchem:PUBCHEM:5284514

Id:5284514

Description:nan